We then derived the two signatures from the training MDS and tested their performances with respect to identification of TB patient groups in the test MDS and two independent TB validation data sets, as well as in the identification of sepsis patients who also present IFN responses. The gene discussed is IFNA1; the disease is tuberculosis.